Generation Bio Co Stock Performance
| GBIO Stock | USD 1.43 0.01 0.69% |
The company retains a Market Volatility (i.e., Beta) of 3.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Generation Bio will likely underperform. At this point, Generation Bio has a negative expected return of -0.82%. Please make sure to check out Generation Bio's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Generation Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Generation Bio Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Disposition of 1590 shares by Phillip Samayoa of Generation Bio at 1.91 subject to Rule 16b-3 | 09/06/2024 |
2 | 7 Top Gene-Editing Stocks to Buy Investing - U.S News World Report Money | 09/17/2024 |
3 | Disposition of 983 shares by Howze Yalonda of Generation Bio subject to Rule 16b-3 | 10/15/2024 |
4 | Vertex Pharmaceuticals Q3 Earnings and Revenues Top Estimates | 11/04/2024 |
5 | Generation Bio GAAP EPS of -0.23, revenue of 7.55M | 11/07/2024 |
6 | Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks | 11/21/2024 |
| Begin Period Cash Flow | 98.9 M |
Generation |
Generation Bio Relative Risk vs. Return Landscape
If you would invest 264.00 in Generation Bio Co on August 30, 2024 and sell it today you would lose (121.00) from holding Generation Bio Co or give up 45.83% of portfolio value over 90 days. Generation Bio Co is currently does not generate positive expected returns and assumes 5.1537% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Generation, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Generation Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Generation Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Generation Bio Co, and traders can use it to determine the average amount a Generation Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1598
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GBIO |
Estimated Market Risk
| 5.15 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.82 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Generation Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Generation Bio by adding Generation Bio to a well-diversified portfolio.
Generation Bio Fundamentals Growth
Generation Stock prices reflect investors' perceptions of the future prospects and financial health of Generation Bio, and Generation Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Generation Stock performance.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.19 | ||||
| Operating Margin | (2.21) % | ||||
| Current Valuation | 5.19 M | ||||
| Shares Outstanding | 66.79 M | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 5.14 X | ||||
| Revenue | 5.9 M | ||||
| EBITDA | (133.3 M) | ||||
| Net Income | (126.61 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 97.89 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 1.56 X | ||||
| Cash Flow From Operations | (52.74 M) | ||||
| Earnings Per Share | (2.17) X | ||||
| Market Capitalization | 95.51 M | ||||
| Total Asset | 374.76 M | ||||
| Retained Earnings | (571.38 M) | ||||
| Working Capital | 232.7 M | ||||
About Generation Bio Performance
By examining Generation Bio's fundamental ratios, stakeholders can obtain critical insights into Generation Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Generation Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (0.99) | (0.94) | |
| Return On Tangible Assets | (0.34) | (0.35) | |
| Return On Capital Employed | (0.41) | (0.43) | |
| Return On Assets | (0.34) | (0.35) | |
| Return On Equity | (0.62) | (0.59) |
Things to note about Generation Bio performance evaluation
Checking the ongoing alerts about Generation Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Generation Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Generation Bio generated a negative expected return over the last 90 days | |
| Generation Bio has high historical volatility and very poor performance | |
| Generation Bio may become a speculative penny stock | |
| Generation Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (126.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Generation Bio Co currently holds about 301.17 M in cash with (52.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 84.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks |
- Analyzing Generation Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Generation Bio's stock is overvalued or undervalued compared to its peers.
- Examining Generation Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Generation Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Generation Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Generation Bio's stock. These opinions can provide insight into Generation Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.